Adeno-associated virus mediated apoA-I and apoA-IMilano expression in skeletal muscular cells  

作　　者：Ming Gui Zhiguang Wang Li Jiang Leming Fan Kejiang Cao Qi Chen Jun Huang 

机构地区：[1]Department of Cardiovascular Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029 [2]Atherosclerosis Research Center,Nanjing Medical University, Nanjing 210029, China

出　　处：《Journal of Nanjing Medical University》2005年第5期236-240,共5页南京医科大学学报（英文版）

基　　金：ProvincialNaturalScienceFoundationoftheDepartmentofEducationofJiangsu(01KJB320003)andInnovationFundofNanjingMedicalUniversity(CX2003001)

摘　　要：Objective： To construct recombinant adeno-associated virus type 2（rAAV2） vectors encoding human apoA-I/apoA-lMilano protein, and explore an effective and safe method to prevent and treat the atherosclerotic diseases. Methods： Human apoA-I cDNA with a His-tag in the upward stream of cDNA sequence were obtained with RT-PCR and PCR, and human apoA-IMilano cDNA was prepared by QuikChange Site-Directed Mutagenesis Kit. After extracted rAAV vectors with a most economic and convenient method, the particle numbers of rAAV vectors were measured by Dot-blot, and the purity was assayed by SOS-Page. The expression efficiency of the apoA-I or apoA-IMilano in C2C12 infected by rAAV vectors were detected by ELISA method. Results： ApoA-I cDNA was gained by RT-PCR and a His-tag was added in the upward stream of apoA-I cDNA successfully. ApoA-I cDNA was mutanted to apoA-IMilano cDNA successfully by QuikChange Site-Directed Mutagenesis Kit. The both titres of the rAAV vectors of apoA-I and apoA-IMilano were about 2×10^14/L, and the result of SOS-Page showed that the purity of the rAAV vectors was satisfied. The expression level of apoA-I was （0.39±0.04） μg/ml and the apoA-IMilano was （0.31±0.03） μ/ml in the DMEM culture medium at the first 24h after transfection. Conclusion： The success of the rAAV vectors construction, purification and the expression of apoA-I and apoA-IMilano in C2C12 cells mediated by these vectors, makes possible to inject rAAVA and rAAVAM vectors into mice muscle, and rises a new hope on finding a new way to prevent and treat atherosclerotic diseases and cardiovascular disease.Objective： To construct recombinant adeno-associated virus type 2（rAAV2） vectors encoding human apoA-I/apoA-lMilano protein, and explore an effective and safe method to prevent and treat the atherosclerotic diseases. Methods： Human apoA-I cDNA with a His-tag in the upward stream of cDNA sequence were obtained with RT-PCR and PCR, and human apoA-IMilano cDNA was prepared by QuikChange Site-Directed Mutagenesis Kit. After extracted rAAV vectors with a most economic and convenient method, the particle numbers of rAAV vectors were measured by Dot-blot, and the purity was assayed by SOS-Page. The expression efficiency of the apoA-I or apoA-IMilano in C2C12 infected by rAAV vectors were detected by ELISA method. Results： ApoA-I cDNA was gained by RT-PCR and a His-tag was added in the upward stream of apoA-I cDNA successfully. ApoA-I cDNA was mutanted to apoA-IMilano cDNA successfully by QuikChange Site-Directed Mutagenesis Kit. The both titres of the rAAV vectors of apoA-I and apoA-IMilano were about 2×10^14/L, and the result of SOS-Page showed that the purity of the rAAV vectors was satisfied. The expression level of apoA-I was （0.39±0.04） μg/ml and the apoA-IMilano was （0.31±0.03） μ/ml in the DMEM culture medium at the first 24h after transfection. Conclusion： The success of the rAAV vectors construction, purification and the expression of apoA-I and apoA-IMilano in C2C12 cells mediated by these vectors, makes possible to inject rAAVA and rAAVAM vectors into mice muscle, and rises a new hope on finding a new way to prevent and treat atherosclerotic diseases and cardiovascular disease.

关 键 词：ATHEROSCLEROSIS APOA-I apoA-IMilano adeno-associated viruse gene transfer 

分 类 号：R511[医药卫生—内科学]